FILE - In this March 14, 2009 file photo, a woman gets ready to check her blood sugar in Sacramento, Calif. (AP Photo/Steve Yeater, File)
COPENHAGEN, Denmark (AP) — Novo Nordisk is recalling 3 million insulin products used for diabetes treatment in 13 European countries due to a production problem that can affect the strength of the drug.
The Danish drug maker says Friday's recall affects certain batches of the prefilled insulin pen NovoMix30 FlexPen in Austria, Belgium, Czech Republic, Denmark, France, Germany, Iceland, Luxemburg, Netherlands, Norway and Slovakia.
It also affects three batches of NovoMix30 Penfill cartridges in Britain and Ireland.
Novo Nordisk says a quality control showed 0.14 percent of the products don't meet the specifications for insulin strength, which could lead to high or low blood sugar levels.
Company spokesman Mike Rulis said there had been no reports of health problems from patients using the affected products, which were first shipped in March.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.